ESSA Pharma Announces Significant Cash Distribution to Shareholders

Author: Ryan Hughes Updated: 08-06-2025 04:41 PM

ESSA Pharma Inc. Approves $80 Million Distribution

ESSA Pharma Inc. (NASDAQ: EPIX) has made a significant announcement regarding a cash distribution to its shareholders. Following a recent decision by the Supreme Court, the company revealed plans for a total cash distribution of $80 million to its common shareholders. This distribution is a key part of the company's winding-down process.

Details of the Cash Distribution

The approved capital return means that shareholders will see approximately $1.91 per common share, which includes the cash payable upon the finalization of an ongoing acquisition deal. This distribution is pivotal as it comes just before a special shareholder meeting aimed at discussing a strategic transaction with XenoTherapeutics, Inc.

Timeline for Payment

Scheduled for payment on a set date, this distribution will go to shareholders who hold shares as of the specified record date. These concrete steps highlight the determination of ESSA Pharma to manage its capital effectively, maintaining shareholder value amid changes in business operations.

Transaction with XenoTherapeutics

As part of broader strategic initiatives, the company is engaged in a transformative transaction with XenoTherapeutics, a non-profit that is set to acquire all outstanding common shares of ESSA. This move is expected to further reshape the company's future, allowing for new growth opportunities.

About ESSA Pharma Inc.

ESSA Pharma, a pharmaceutical entity, has been dedicated to developing innovative treatments for prostate cancer. With a focus on proprietary therapies, ESSA aims to address unmet medical needs within oncology. The strategic initiatives underscore the company's commitment to its mission while adapting to new market environments.

Contact Information for Shareholders

David Wood, the Chief Financial Officer, is available for inquiries from shareholders regarding this recent announcement. He can be reached at 778-331-0962 for any questions or clarifications regarding the distribution process or upcoming shareholder meeting.

Frequently Asked Questions

What is the amount of the cash distribution announced by ESSA Pharma?

The company has announced a cash distribution totaling $80 million to shareholders.

When will the distribution be paid to shareholders?

The cash distribution is scheduled to be paid on a specific date to shareholders of record.

What is the purpose of the cash distribution?

This distribution is part of the company's plan for winding down operations while ensuring shareholder value.

How much will each shareholder receive in this distribution?

Each shareholder is expected to receive approximately $1.91 per common share based on this distribution.

What transaction is ESSA Pharma currently involved in?

ESSA is undergoing a strategic transaction with XenoTherapeutics for the acquisition of all outstanding common shares as part of their future plans.

About The Author

Hello, my name is Ryan Hughes. I am a financial, economics, and stock market specialist committed to assisting people in negotiating the intricacies of the financial system. Having a great deal of experience and a thorough grasp of market dynamics and economic trends, my area of expertise is converting complex financial ideas into understandable, practical knowledge. By use of my articles and blog entries, I hope to give you the information and assurance you need to make wise financial choices.

I've had the honor of interacting with a wide range of readers as a writer for several financial blogs, from new investors to seasoned market participants. To enable you to reach your financial goals, I want to make finance, economics, and stock market trends understandable and approachable. I appreciate you traveling with me toward success and financial literacy.

Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.